Koyfin Home > Directory > Health Care > Arena Pharmaceuticals > EV / Sales (ntm)

Arena Pharmaceuticals EV / Sales (ntm) Chart (ARNA)

Arena Pharmaceuticals annual/quarterly EV / Sales (ntm) from 2001 to 2018.
  • Arena Pharmaceuticals EV / Sales (ntm) for the quarter ending March 03, 2018 was 113.84 a 80.29% increase of 91.39 year over year
  • Arena Pharmaceuticals Annual EV / Sales (ntm) for 2017 was 44.24 a 82.02% increase of 36.29 from 2016
  • Arena Pharmaceuticals Annual EV / Sales (ntm) for 2016 was 7.96 a -49.20% decrease of -3.91 from 2015
  • Arena Pharmaceuticals Annual EV / Sales (ntm) for 2015 was 11.87 a -31.02% decrease of -3.68 from 2014
Other Valuation Metrics:
  • Arena Pharmaceuticals Market Cap for the quarter ending March 03, 2018 was $1,938m a 72.36% increase of 1,402m year over year
  • Arena Pharmaceuticals Price / Book for the quarter ending March 03, 2018 was 7.49 a -168.68% decrease of -12.63 year over year
  • Arena Pharmaceuticals Enterprise Value for the quarter ending March 03, 2018 was $1,752m a 70.30% increase of 1,232m year over year
View Chart On Koyfin

Quarterly ARNA EV / Sales (ntm) Data

03/2018113.84
12/201744.24
09/201739.00
06/201722.44
03/201716.38
12/20167.96
09/20168.07
06/20167.94
03/20168.04
12/201511.87

Annual ARNA EV / Sales (ntm) Data

201744.24
20167.96
201511.87
201415.55
201316.74
201214.01
201123.90
20108.64
200913.89
200810.17